Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation
- PMID: 37833526
- DOI: 10.1038/s41409-023-02125-x
Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation
References
-
- Copelan EA. Hematopoietic stem-cell transplantation. N. Engl J Med. 2006;354:1813–26. https://doi.org/10.1056/NEJMra052638 . - DOI - PubMed
-
- Cluzeau T, Lambert J, Raus N, Dessaux K, Absi L, Delbos F, et al. Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI. Bone Marrow Transpl. 2016;51:687–91. https://doi.org/10.1038/bmt.2015.351 . - DOI
-
- Zhao Y, Gao F, Shi J, Luo Y, Tan Y, Lai X, et al. Incidence, risk factors, and outcomes of primary poor graft function after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2019;25:1898–907. https://doi.org/10.1016/j.bbmt.2019.05.036 . - DOI
-
- Shahzad M, Siddiqui RS, Anwar I, Chaudhary SG, Ali T, Naseem M, et al. Outcomes with CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. Transpl Cell Ther. 2021;27:877.e1–e8. https://doi.org/10.1016/j.jtct.2021.07.012 . - DOI
-
- Klyuchnikov E, El-Cheikh J, Sputtek A, Lioznov M, Calmels B, Furst S, et al. CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies. Biol Blood Marrow Transpl. 2014;20:382–6. https://doi.org/10.1016/j.bbmt.2013.11.034 . - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
